Beyondspring

BYSI70

Penny Stock

$1.740.00%$0.00

Penny Stock

BYSI70

$1.74

0.00%$0.00

Penny Stock

Performance History

Key Stats
Open	$1.73
Prev. Close	$1.74
EPS	-0.40
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$70.12M
PE Ratio	-

	LOW	HIGH
Day Range	1.67	1.76
52 Week Range	0.65	4.00

Ratios







EPS	-0.40

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Beyondspring (BYSI)

BeyondSpring Inc. (BYSI) is a global biopharmaceutical company focused on the development of innovative cancer therapies. The company is committed to improving the lives of patients by advancing new treatment options. With a strong pipeline of potential therapies, BYSI is well-positioned to address unmet needs in oncology. The company's lead product candidate, Plinabulin, is being evaluated in multiple clinical trials for various types of cancer. Plinabulin has shown promising results in early studies, demonstrating its potential to enhance the effectiveness of chemotherapy and improve outcomes for patients.

BYSI is dedicated to delivering value to shareholders, as evidenced by its strong financial performance. The company has achieved significant revenue growth in recent years, driven by the successful development and commercialization of its products. With its expanding product portfolio and strategic partnerships, BYSI is well-positioned for continued growth in the future. The company's market cap reflects the confidence of investors in its potential, and its stock price history demonstrates its ability to generate solid returns for shareholders.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Lan Huang Ph.D.
Headquarters: New York
Employees: 73
Exchange: NASDAQ

Keep an eye on Beyondspring

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Beyondspring 's (BYSI) price per share?

The current price per share for Beyondspring (BYSI) is $1.74. The stock has seen a price change of $0 recently, indicating a 0% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Beyondspring (BYSI)?

For Beyondspring (BYSI), the 52-week high is $4, which is 129.89% from the current price. The 52-week low is $0.65, the current price is 166.46% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Beyondspring (BYSI) a growth stock?

Beyondspring (BYSI) has shown an average price growth of -4.13% over the past three years. It has received a score of 70 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Beyondspring as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Beyondspring (BYSI) stock price performance year to date (YTD)?

As of the latest data, Beyondspring (BYSI) has a year-to-date price change of 103.27%. Over the past month, the stock has experienced a price change of -21.38%. Over the last three months, the change has been -8.18%. Over the past six months, the figure is -36.5%. Looking at a longer horizon, the five-year price change stands at -87.87%.

help

Is Beyondspring (BYSI) a profitable company?

Beyondspring (BYSI) has a net income of -$21.03M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -742.2% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $1.75M, with a revenue growth rate of 29.61%, providing insight into the company's sales performance and growth. The gross profit is $1.75M. Operating income is noted at -$23.11M. Furthermore, the EBITDA is -$16.72M.

help

What is the market capitalization of Beyondspring (BYSI)?

Beyondspring (BYSI) has a market capitalization of $70.12M. The average daily trading volume is 1.72, indicating the stock's liquidity and investor engagement.

News

IMMUNE CHECKPOINT INHIBITORS

Nov 11, 2024

BeyondSpring Presents Updated Efficacy Results from a Phase 2 IIT Study of Triple IO Combo of Pembrolizumab plus Plinabulin/Docetaxel in Metastatic NSCLC after Progressing on Prior Immune Checkpoint Inhibitors at the 39th SITC Annual Meeting

BeyondSpring Presents Final Data Analysis of DUBLIN-3 Phase 3 Study in 2L/3L EGFR Wild-type NSCLC at ESMO Congress 2024

BEYONDSPRING

PLINABULIN

NON-SMALL CELL LUNG CANCER

ESMO CONGRESS 2024

WORLD CONFERENCE ON LUNG CANCER

Sep 3, 2024

BeyondSpring Announces Oral Presentation at the 2024 World Conference on Lung Cancer and Two Poster Presentations During ESMO Congress 2024 Showcasing its Lead Anti-Cancer Asset, Plinabulin

CALENDAR OF EVENTS

May 3, 2024

BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics

COMPANY REGULATORY FILINGS

Apr 29, 2024

BeyondSpring Files 2023 Annual Report on Form 20-F

EARNINGS RELEASES AND OPERATING RESULTS

Apr 29, 2024

BeyondSpring Provides Business Update and Reports Year End 2023 Financial Results